Clinical Trial Update: PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring PD-1 monoclonal antibody plus apatinib with SBRT for hepatocellular carcinoma with portal vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• PD-1 monoclonal antibody

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: HCC | Phase 2 | Status: UNKNOWN